Overview
The Clinton Health Access Initiative, Inc. (CHAI) is a global health
organization committed to saving lives and reducing the burden of disease in
low-and middle-income countries (LMICs), while strengthening the capabilities
of governments and the private sector in those countries to create and sustain
high-quality health systems that can succeed without our assistance. For more
information, please visit: https://www.clintonhealthaccess.org
CHAI Vaccines program
Immunization is one of the most successful public health interventions in
history. National immunization programs reach more than 100 million infants
every year and have averted globally, two to three million deaths every year
since the launch of the Expanded Program for Immunization (EPI) in 1974, whilst
the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1
million lives per year. Furthermore, great advances in discovering and
financing new vaccines provide a great opportunity for countries to further
reduce the burden of disease due to virus such as the human papillomavirus
(HPV). Despite these successes, 1.5 million children still die each year of
vaccine-preventable diseases, many of them in low-income countries, as
immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative has worked to save lives and
reduce the burden of vaccine-preventable-diseases by improving access to
immunization services in resource-limited settings, by strengthening national
immunization programs, and by leveraging its experience working in low-income
countries to improve the global immunization ecosystem.
Overview of the CHAI Indonesia and New Vaccine Introduction work
CHAI started supporting Indonesia’s Ministry of Health in 2010 to scale up
adult anti-retroviral therapy, through improving supply chain management; as
well as technical assistance for improving the quality of ART and laboratory
systems to support HIV care and treatment. In recent years, CHAI has expanded
its support to the Ministry of Health to other areas including hepatitis and
helping to facilitate BMS to and donate pan genotyping DAA, daclatasvir, more
effective treatment for HCV patient, improving access to family planning, point
of care diagnostics, mhealth, maternal and child health, scooping assistive
technology in Indonesia so no one left behind, and technical support for the
Ministry of Health’s drive to sustainably fund healthcare. In mid-2016, CHAI
launched its vaccines program to support the EPI and Ministry of Health in
Indonesia introduce the Pneumococcal Conjugate Vaccine (PCV) and strengthen
broader immunization systems, including cold chain, supply chain, and
immunization financing, among other things. From 2017-2019 CHAI supported the
government execute a PCV demonstration project in select districts as well as
support national-level decision-making on PCV introduction.
In early 2020, the government of Indonesia announced their decision to
introduce PCV nationwide and to procure vaccines through the Advance Market
Commitment (AMC). CHAI will continue to support the government with PCV
introduction, by focusing on the following objectives:
- Support the government of Indonesia in central-level planning, resource
mobilization, and adoption of best practices from the demonstration project to
prepare a strong PCV introduction
- Support the government of Indonesia in operationalizing the new
procurement mechanism through AMC and ensuring strong distribution channels to
provinces
- Support provincial and district governments in planning and completing all
key PCV preparatory activities on time and with a high degree of quality and
financial and programmatic autonomy
- Support the government of Indonesia to attain and thereafter sustain high
PCV coverage on an accelerated timeline through quick identification and
resolution of post-introduction bottlenecks
In addition to PCV, the government of Indonesia is planning for several
additional new vaccine introductions over the coming years and CHAI may in the
future be brought in to provide support beyond PCV.
Overview of the Vaccines Program Officer role
Reporting to the Program Manager, the Program Officer will support efforts to
deliver the ambitious objectives of PCV work and any future new vaccine
introduction work that may be added to CHAI’s scope of work. S/he will provide
both strategic and technical support to the government of Indonesia in planning
and implementing PCV introduction, including but not limited to: data analysis,
synthesis of research/information in memos and presentations, design of data
collection tools, training material, and compilation of lessons learned and
best practices. The program officer will work closely with all members of the
Indonesia Vaccines program as well as CHAI’s Global Vaccines Delivery team.
Responsibilities
- Provide strategic and administrative support to Program Manager to ensure
smooth and successful program development and implementation
- Ensure effective communication with key local partners and internal
program for better coordination and planning
- Operationalize and implement recommendations and technical guidance as
agreed with local partners
- Support government partners with planning, analytics, problem-solving and
implementing of their PCV introduction strategy
- Work closely with CHAI’s sub-national vaccines officers to support partner
sites (Provincial and District Office of Health, Primary Health centre and
other related local government bodies), including communities to ensure the
success of the PCV program
- Facilitate monitoring, evaluation and analysis for continuous program
adaptation and improvement
- Ensure the documentation of activities and outcomes in order to create
replicable models and policy advocacy documents
- Perform basic finance and admin functions as needed under the guidance of
the CHAI Finance team.
- Perform any other tasks assigned by the Program Manager and or Senior
Program Manager and or Program Director.
Qualifications
- At least a bachelor degree in a public health or a quantitative discipline
- At least three years of work experience within a demanding and
results-driven environment
- Strong analytical skills and ability to think strategically and in a
change-oriented manner
- Entrepreneurial ability to work quickly and effectively with minimal
supervision
- Sensitivity to cultural contexts
- Ability to handle multiple tasks simultaneously, set priorities, and meet
deadlines and to absorb and synthesize a broad range of information
- Strong leadership and diplomacy skills
- The ability to build relationships and influence stakeholders
- Proven track record working in challenging multi-stakeholder environments
- Excellent attitude to the work and self-motivated persona
- Experience working in unpredictable environment, willingness to adapt
- Fluently in English (oral and written) and in Indonesian
- Experience in healthcare, and knowledge of the Indonesian Health System is
an advantage
HOW TO APPLY
Interested candidates shall submit CV Resume and application to
cnatalia@xxxxxxxxxxxxxxxxxxxxxxx no later than August 21, 2020 with email
subject Program Officer, Vaccine.
Only shortlisted candidates will be notified.